Improving Outcomes in Chronic Obstructive Pulmonary Disease
Optimizing Maintenance Therapy Across Healthcare Settings
eBook Download
Available for download with iBooks on your Mac or iOS device:
Click Here for Download
Guidelines
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015.
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation.
Rennard S, et al. COPD. 2013;10(3):378-389.
Patient Resources
American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy, and research..
COPD Foundation
The COPD Foundation’s mission is to prevent and cure Chronic Obstructive Pulmonary Disease and to improve the lives of all people affected by COPD.
American College of CHEST Physicians (CHEST Foundation)
The mission of CHEST Foundation is to develop resources to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD)
GOLD partners with health care professionals and public health officials to raise awareness of Chronic Obstructive Pulmonary Disease (COPD) and to improve prevention and treatment of this lung disease for patients around the world.
Suggested Readings
Use of spirometry in the diagnosis of COPD: a qualitative study in primary care.
Joo MJ, et al. COPD. 2013;10(4):444-449.
Employment and activity limitations among adults with chronic obstructive pulmonary disease—United States, 2013
Wheaton AG, et al. MMWR Morb Mortal Wkly Rep. 2015;64(11):289-295.
Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ, et al. Cochrane Database Syst Rev. 2012;12:CD010257.
Nebulized arformoterol: what is its place in the management of COPD?
Miles MC, et al. Ther Adv Respir Dis. 2013;7(2):81-86.
Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
Mahler DA, et al. J Aerosol Med Pulm Drug Deliv. 2014;27(2):103-109.
Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.
Barrons R, et al. Am J Health Syst Pharm. 2011;68(13):1221-1232.
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD.
Bollu V, et al. Int J Chron Obstruct Pulmon Dis. 2013;8:631-639.
Factors affecting chronic obstructive pulmonary disease early rehospitalization.
Nantsupawat T, et al. Chron Respir Dis. 2012;9(2):93-98.
Assessment of the factors affecting the failure to use inhaler devices before and after training.
Aydemir Y. Respir Med. 2015;109(4):451-458.
Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next?
Bender, BG. Curr Opin Pulm Med. 2014;20(2):132-137.
Optimizing Maintenance Therapy Across Health Care Settings
Relevant Resources
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
A New Era in Precision Medicine
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Evolving Best Practices to Optimize Outcomes
Consensus and Controversies on the Road to Precision Medicine
Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care
The PCP’s Role in Timely Recognition and Referral
Debates and Discussions About Personalizing Patient Management
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
From Guideline Recommendations to Daily Clinical Decision-Making
Improving Patient Outcomes Through Shared Clinical Decision Making
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Improving Patient Outcomes Through Shared Clinical Decision Making
Digging Deep on Shared Decision-Making
Mechanistic Insights and Evolving Treatment Options
Clinical Resource Center
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
Mechanistic Insights and Emerging Treatment Options
A PrEP Primer
A Foundation for Managed Care
A Focus on Exacerbation Prevention
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
What the Pharmacist Needs to Know about PrEP
Unlocking Novel Paths to Patient Care
Evolving Best Practices for Patient Management
The Increasing Role of JAK Inhibitors
Shared Decision-making in the Era of Biologics
New Pathways to Patient Management
From Comprehensive Patient Evaluations to Individualized Evidence-based Care
Preventing COPD Exacerbations to Improve Outcomes
A Whole Patient Case Series
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Evolving Best Practices for Pediatric Patients
